Receiving a liver transplant from a living donor is associated with an increased risk — as much as four times higher — of disease recurrence…
Cholangitis
LIVER DISEASE
NewsEarly detection highlighted in this year’s Rare Liver Diseases Month
February is Rare Liver Diseases Month, and this year, the Global Liver Institute (GLI) is highlighting the importance of early diagnosis for better health…
People who are exposed to more sunlight over their lifetimes are less likely to develop primary biliary cholangitis (PBC), a study shows. “This suggests…
CHOLANGITIS
NewsGenetic analysis unveils 3 potentially key treatment targets for PSC
Researchers have identified three proteins that may be key targets for treating primary sclerosing cholangitis (PSC), and one of these proteins may also be…
Vitamin D was shown to ease the effects of liver inflammation and damage in primary biliary cholangitis (PBC), a chronic form of cholangitis,…
CHOLANGITIS
NewsNew study finds higher cancer risk in PSC with advanced dysplasia
Liver transplant may help prevent bile duct cancer in people with primary sclerosing cholangitis (PSC) who have advanced bile duct dysplasia, a serious…
LIVER DISEASE
NewsTop 10 Liver Disease News stories of 2025
Throughout 2025, the team at Liver Disease News has reported on the latest research and advances in care related to various rare and non-rare liver…
CHOLANGITIS
NewsCompound found in honey reduced inflammation in PBC mice in lab
Galangin, a naturally occurring compound found in honey and certain plants, was shown to reduce inflammation and liver injury in a mouse model of…
CHOLANGITIS
NewsPSC-IBD study shows need for regional management guidelines
The frequency of primary sclerosing cholangitis (PSC) in people with inflammatory bowel disease (IBD) is lower in Asian countries than in the West, according…
The experimental oral therapy linerixibat from GlaxoSmithKline (GSK) offers rapid and sustained relief from severe itch in adults with primary biliary cholangitis (PBC),…
Recent Posts
- One of my superpowers for MASH is defiance in the name of compliance
- Canada approves Livmarli oral tablets for Alagille itching
- New experimental therapy enters early human testing for hepatitis B
- Risk of PSC recurrence 4 times higher with living donor transplant: Study
- Early detection highlighted in this year’s Rare Liver Diseases Month